Literature DB >> 30666748

Commentary on Jones & McCance-Katze (2019): Buprenorphine and the glass half full-why can't we prescribe more of it, and will nurse practitioners and physician assistants fulfill a chronic unmet need?

Joshua D Lee1, Jennifer McNeely.   

Abstract

Entities:  

Keywords:  Buprenorphine; X-waiver; nurse practitioner; opioid use disorders; pharmacotherapy; physician assistant; primary care

Mesh：

Substances：

Year:  2019        PMID： 30666748     DOI： 10.1111/add.14545

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  2 in total

1.  Innovations in efforts to expand treatment for opioid use disorder.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2019-08-21       Impact factor: 4.018

2.  Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing.

Authors:  Barbara Andraka-Christou; Adam J Gordon; Joanne Spetz; Rachel Totaram; Matthew Golan; Olivia Randall-Kosich; Jordan Harrison; Spencer Calder; Stefan G Kertesz; Bradley D Stein
Journal:  J Subst Abuse Treat       Date:  2022-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.